- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-EMAP II
EMAP II Polyclonal Antibody for WB, IHC, IF/ICC, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris et plus (1)
Applications
WB, IHC, IF/ICC, IP, ELISA
Conjugaison
Non conjugué
N° de cat : 11091-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules HeLa, cellules A549, cellules SGC-7901, cellules SH-SY5Y, cellules U-251, tissu cérébral de souris |
| Résultats positifs en IP | cellules SGC-7901, |
| Résultats positifs en IHC | tissu de cancer du col de l'utérus humain, il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. |
| Résultats positifs en IF/ICC | cellules HeLa, |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochimie (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| KD/KO | See 1 publications below |
| WB | See 6 publications below |
| IHC | See 1 publications below |
| IF | See 1 publications below |
Informations sur le produit
11091-1-AP cible EMAP II dans les applications de WB, IHC, IF/ICC, IP, ELISA et montre une réactivité avec des échantillons Humain, souris
| Réactivité | Humain, souris |
| Réactivité citée | rat, Humain |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | EMAP II Protéine recombinante Ag1560 |
| Nom complet | small inducible cytokine subfamily E, member 1 (endothelial monocyte-activating) |
| Masse moléculaire calculée | 34 kDa |
| Poids moléculaire observé | 34 kDa and 68 kDa |
| Numéro d’acquisition GenBank | BC014051 |
| Symbole du gène | EMAP II |
| Identification du gène (NCBI) | 9255 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
SCYE1(small inducible cytokine subfamily E, member 1) is also named as EMAP2, AIMP1. The human cDNA encodes a 312-amino acid polypeptide that the predicted 34-kDa precursor can be cleaved to produce an active 20-kDa product(PMID:7929199). SCYE1 is secreted as a result of various stimuli, including TNF-α, heat shock, and hypoxia, and that it acts as a multifunctional cytokine on both endothelial and immune cells(PMID:18292511). Defects in AIMP1 are the cause of leukodystrophy hypomyelinating type 3 (HLD3). It has 2 isoforms produced by alternative splicing and the protein can exsit as a dimer(PMID:11306575).
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for EMAP II antibody 11091-1-AP | Download protocol |
| IHC protocol for EMAP II antibody 11091-1-AP | Download protocol |
| IF protocol for EMAP II antibody 11091-1-AP | Download protocol |
| IP protocol for EMAP II antibody 11091-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
Mol Cell A methyltransferase-independent role for METTL1 in tRNA aminoacylation and oncogenic transformation | ||
Cancer Lett Trim21-mediated HIF-1α degradation attenuates aerobic glycolysis to inhibit renal cancer tumorigenesis and metastasis. | ||
J Biol Chem Structural control of caspase-generated glutamyl-tRNA synthetase by appended noncatalytic WHEP domains. | ||
Proteomics Mass Spectrometric Analysis Identifies AIMP1 and LTA4H as FSCN1-Binding Proteins in Laryngeal Squamous Cell Carcinoma. | ||
Int J Mol Med Changes in the expression of endothelial monocyte‑activating polypeptide II in the rat hippocampus following status epilepticus. | ||
Cancer Commun (Lond) AIMP1 promotes multiple myeloma malignancy through interacting with ANP32A to mediate histone H3 acetylation |
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.
FH Krishnendu (Verified Customer) (02-27-2020) | Very strong antibody and works nicely for both WB and IP.
|





